| CODEXIS INC. DL-,01 |
| USA |
| Gesundheit |
| US1920051067 / A0Q2S4 |
| 4QK (Frankfurt) / CDXS (NASDAQ) |
| FRA:4QK, ETR:4QK, 4QK:GR, NASDAQ:CDXS |
| - |
| http://www.codexis.com/ |
|
Codexis Inc. operates within the biotechnology sector, specializing in the engineering of enzymes and proteins to serve diverse industries. The company's primary function is to harness its proprietary..
>Volltext.. |
| 99.55 Mio. EUR |
| 94.87 Mio. EUR |
| 61.09 Mio. EUR |
| -28.07 Mio. EUR |
| -38.16 Mio. EUR |
| -0.45 EUR |
| 63.53 Mio. EUR |
| 44.5 Mio. EUR |
| -16.82 Mio. EUR |
| 3.11 |
| 4.54% |
| 40.62% |
| - |
| - |
| - |
| CODEXIS |
| 14.03.26 |
|